Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,328 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year outcome of joint destruction (RECONFIRM-2J).
Takeuchi T, Yamanaka H, Inoue E, Nagasawa H, Nawata M, Ikari K, Saito K, Sekiguchi N, Sato E, Kameda H, Iwata S, Mochizuki T, Amano K, Tanaka Y. Takeuchi T, et al. Among authors: amano k. Mod Rheumatol. 2008;18(5):447-54. doi: 10.1007/s10165-008-0077-5. Epub 2008 May 21. Mod Rheumatol. 2008. PMID: 18493716
Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year clinical outcomes (RECONFIRM-2).
Tanaka Y, Takeuchi T, Inoue E, Saito K, Sekiguchi N, Sato E, Nawata M, Kameda H, Iwata S, Amano K, Yamanaka H. Tanaka Y, et al. Among authors: amano k. Mod Rheumatol. 2008;18(2):146-52. doi: 10.1007/s10165-008-0026-3. Epub 2008 Feb 19. Mod Rheumatol. 2008. PMID: 18283523 Free PMC article.
Efficacy and tolerability of tocilizumab in rheumatoid arthritis patients seen in daily clinical practice in Japan: results from a retrospective study (REACTION study).
Yamanaka H, Tanaka Y, Inoue E, Hoshi D, Momohara S, Hanami K, Yunoue N, Saito K, Amano K, Kameda H, Takeuchi T. Yamanaka H, et al. Among authors: amano k. Mod Rheumatol. 2011 Apr;21(2):122-33. doi: 10.1007/s10165-010-0366-7. Epub 2010 Oct 16. Mod Rheumatol. 2011. PMID: 20953815 Free PMC article. Clinical Trial.
Messenger ribonucleic acid expression profile in peripheral blood cells from RA patients following treatment with an anti-TNF-alpha monoclonal antibody, infliximab.
Sekiguchi N, Kawauchi S, Furuya T, Inaba N, Matsuda K, Ando S, Ogasawara M, Aburatani H, Kameda H, Amano K, Abe T, Ito S, Takeuchi T. Sekiguchi N, et al. Among authors: amano k. Rheumatology (Oxford). 2008 Jun;47(6):780-8. doi: 10.1093/rheumatology/ken083. Epub 2008 Apr 3. Rheumatology (Oxford). 2008. PMID: 18388148
Prediction of efficacy of anti-TNF biologic agent, infliximab, for rheumatoid arthritis patients using a comprehensive transcriptome analysis of white blood cells.
Tanino M, Matoba R, Nakamura S, Kameda H, Amano K, Okayama T, Nagasawa H, Suzuki K, Matsubara K, Takeuchi T. Tanino M, et al. Among authors: amano k. Biochem Biophys Res Commun. 2009 Sep 18;387(2):261-5. doi: 10.1016/j.bbrc.2009.06.149. Epub 2009 Jul 3. Biochem Biophys Res Commun. 2009. PMID: 19577537
1,328 results